Evaluation of Woulgan in Diabetic Foot Ulcer

Clinical trial NCT02631512 · COMPLETED

Trial details

NCT number: NCT02631512
Sponsor: Biotec Pharmacon ASA
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Foot Ulcers

Start date: 2015-10-01
Primary completion: 2018-12-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.